The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1611
ISSUE1611
November 16, 2020
Minocycline Foam (Zilxi) for Rosacea
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Minocycline Foam (Zilxi) for Rosacea
November 16, 2020 (Issue: 1611)
The FDA has approved a 1.5% topical foam formulation
of minocycline (Zilxi – Foamix) for treatment of
inflammatory lesions of rosacea in adults. It is
the only topical minocycline product approved for
this indication. The same manufacturer...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.